Abstract
The dynamics of the increase in illnesses, including oncological diseases, causes a different view on the scope of insurance protection offered by insurance companies. The way to limit the risks inherent in life insurance should not just be to add inclusions to offers. It is possible for insurance companies to focus on other activities that may not only reduce the consequences of liability for specific risks but also improve the offer and product sales. The purpose of the chapter is to demonstrate the increasing risk of cancer in life insurance and its consequences. The study contains not only to analyse examples of designs of health insurance products with the option of insurance against cancer, the so-called “cancer cover type health insurance”, but also to demonstrate the benefits of supplementing insurance products with additional elements to reduce the potential effects of negative events. Presentation of the experiences of one country (Poland) in this respect should become the opening for a debate on the form of offers constructed by insurance companies in different countries, which could be beneficial for economic and social security of the insured.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ambroggi M. (et al.), 2015, Distance as a barrier to cancer diagnosis and treatment: Review of literature, The Oncologist, 20, 12, 1379–1383
Biuletyn statystyczny Ministerstwa Zdrowia, Centrum Systemów Informacyjnych Ochrony Zdrowia 2019.
Caplan, G. (1964). Principles of prevention psychiatry. New York: Basic Books.
Diagnostic services in oncology. The problem of scarce re-sources. Economic and Environmental Studies, www.ees.uni.opole.pl. ISSN paper version 1642–2597, ISSN electronic version 2081–8319.
Dostęp pacjentów onkologicznych do terapii lekowych w Polsce na tle aktualnej wiedzy medycznej, Raport 2017, ALIVA Fundacja Onkologiczna 2017.
Fundacji im. L. Pagi. (2019). Pokłady cyfrowego bogactwa w służbie pacjentom, czyli o wykorzystaniu potencjału danych w sektorze ochrony zdrowia, Raport Alumnów projektu „Liderzy ochrony zdrowia”.
https://axa.pl/pomoc-na-raka/ (2017).
https://www.nn.pl/rakowi-wspak (2017).
Metodyka pomiaru kosztów pośrednich w polskim systemie ochrony zdrowia, Raport EY, Program EY Sprawne Państwo, 2013.
OECD/EU. (2016). Health at a glance: Europe 2016. State of health in the EU cycle. Paris: OECD.
Poprawa efektywności i stabilności opieki onkologicznej. Rekomendacje dla Polski, Raport inicjatywy All. Can., 2017.
Ruszkowski, J., & Leśniowska, J. (2010). Rzeczywiste, ekonomiczne koszty choroby w Polsce. http://www.pszw.edu.pl/images/publikacje/t025_pszw_2010_ruszkowski_lesniowska_-_rzeczywiste_ekonomiczne_koszty_choroby_w_polsce.pdf.
Sowada, C., Sagan, A., & Kowalska-Bobko, I. (2019). Poland: Health system review. Health Systems in Transition, 21(1), 1–234.
Systemy opieki onkologicznej w wybranych państwach, Raport EY, Program EY Sprawne Państwo, 2014.
World Cancer Report. (2008). Peter Boyle and Bernard Levin, IARC, Lyon
www.mpz.mz.gov.pl.
www.piu.org.pl.
Zawadzki, P. (2017). Wpływ badań przesiewowych w zakresie badań raka piersi na poprawę efektywności finansowej systemu opieki medycznej w Polsce. Nauki Zarządzaniu Management Sciences, 3(32).
Zdrowie i ochrona zdrowia w 2017r Health and healthcare in 2017, Analizy statystyczne GUS
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Węgrzyn, M. (2020). Discussion of Reducing the Risk of Cancer in Life and Health Insurance. In: Borda, M., Grima, S., Kwiecień, I. (eds) Life Insurance in Europe. Financial and Monetary Policy Studies, vol 50. Springer, Cham. https://doi.org/10.1007/978-3-030-49655-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-49655-5_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-49654-8
Online ISBN: 978-3-030-49655-5
eBook Packages: Economics and FinanceEconomics and Finance (R0)